Exclusive: Archambeau loses key powers over EUIPO contract row
Managing IP is part of Legal Benchmarking Limited, 4 Bouverie Street, London, EC4Y 8AX
Copyright © Legal Benchmarking Limited and its affiliated companies 2024

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Exclusive: Archambeau loses key powers over EUIPO contract row


The EUIPO management board has suspended some of the executive director's powers after he demanded compensation for the non-renewal of his mandate

  • Details of shock decision from EUIPO management board

  • Inside insight into contract row that led to yesterday's meeting

The EUIPO has suspended key administrative powers held by executive director Christian Archambeau, Managing IP can reveal.

Jorma Hanski, chairperson of the EUIPO management board, sent an email to EUIPO staff this morning, March 7, to inform them of the news.

The decision was taken at an extraordinary meeting of the management board yesterday, March 6, after Archambeau filed a claim for compensation over the non-renewal of his contract.

Archambeau is seeking compensation worth €400,000 ($426,000) in lost earnings and €75,000 in damages, sources with knowledge of the meeting told Managing IP.

The advertised salary for Archambeau's successor is €211,680 per annum.

From now until the end of his term in October, Archambeau will no longer be able to authorise contracts on behalf of the EUIPO and exercise other key powers as a result of the row.

Hanski wrote: “I would like to inform you in line with Article 4(f) of Decision MB-17-01 that the management board decided to temporarily suspend the powers of the appointing authority (AIPN) and of the authority authorised to conclude contracts of employment (AACC), delegated by the management board to the executive director.

“The suspension takes effect as of today, 7 March 2023, until the end of executive director’s mandate.”

The AIPN powers are conferred on the executive director by the management board, in line with the EU staff regulations.

The suspended duties assigned to Archambeau will now be carried out by Hanski until a new executive director is appointed.

Archambeau, a Belgian national, has served as EUIPO executive director since October 2018 but will depart the post later this year.

Last November, a joint meeting of the management board and budget committee voted to remove Archambeau at the end of his contract in October 2023.

At that meeting, Archambeau faced criticism over the slump in EU trademark filings last year and the financial repercussions for national intellectual property offices.

The EUIPO’s poorer-than-expected financial performance last year will mean that, under EUIPO rules, the office cannot deliver lucrative offsetting payments to member states in 2024.

These payments compensate member states for the costs of administering the EU trademark system.

There are three known candidates to replace Archambeau as executive director, each with government support – Italy’s Andrea Di Carlo, Portugal’s João Negrão, and France’s Etienne Sanz de Acedo.

A pre-selection panel will interview candidates and submit at least three names for consideration by the management board at its next scheduled meeting in June.

The board's pick is then subject to formal approval by the European Council.

Archambeau declined to comment on this story when contacted by Managing IP.

more from across site and ros bottom lb

More from across our site

Abion said the appointment of Silvia Asioli and the launch of its Milan office will expand its market position in southern Europe
UK firms who have hired litigation and transactional lawyers reveal how they work together and the lessons have they learned
Jonah Mitchell tells us why he would have liked to have tried his hand at being a firefighter or chef
Noemi Parrotta, chair of the European subcommittee within INTA’s International Amicus Committee, explains why we might not have heard the last of the morality debate
Counsel say the USPTO's examples of AI patentability should make their lives easier and help point clients in the right direction
We provide a rundown of Managing IP’s news and analysis from the week, and review what’s been happening elsewhere in IP
Ehsun Forghany says he was impressed by the firm's focus on fashion and IP as well as the expertise of chairman Anthony Lupo
Counsel at medical device companies say the unitary patent, AI and terminal disclaimers are major areas of concern
The LMG Life Sciences Awards is thrilled to present the shortlist for the 2024 Ameicas Awards
Daniel Wise at Carpmaels & Ransford explains how he helped secure the first UPC revocation ruling on behalf of Sanofi and Regeneron against Amgen
Gift this article